ISSN: 2222-6990
Open access
3D Bioprinting is a rapidly emerging technology and has the potential to benefit future medical and healthcare sectors. However, 3D bioprinting are facing challenges in its implementation particularly with regards to patient’s consent. There are two research objectives in this study, firstly, to examine the doctrine of informed consent and its application in medical treatment using 3D bioprinting and secondly, to recommend changes in Consent Guidelines in Malaysian Medical Council incorporating informed consent guideline for medical treatment using 3D bioprinting. This study contributes in the field of 3D bioprinting and it has expanded the discussion on doctrine of informed consent by applying it into 3D bioprinting. This is a qualitative study which employs content analysis method. Findings shows that there is a dire need for a clear guideline for medical practitioner to get patient’s consent in receiving medical treatment particularly by using 3D bioprinting in order to avoid any claims and suits that occurs due to medical negligence in specific, failing to ensure informed consent is obtained from patient before medical treatment is done. It is recommended to update the Malaysian Medical Council to update the guideline on obtaining informed consent in 3D bioprinting medical treatment. Future studies can address the application of informed consent in medical treatment using 3D bioprinting through quantitative study.
Dababneh, A. B., and Ozbolat, I. T. (2014). Bioprinting technology: a current state-of-the-art review. Journal of Manufacturing Science and Engineering: 136(6).
Guillemot, F., Mironov, V., and Nakamura, M. (2010). Bioprinting is coming of age: report from the International Conference on Bioprinting and Biofabrication in Bordeaux (3B'09). Biofabrication, 2(1): 010- 201.
Gungor-Ozkerim, P. S., Inci, I., Zhang, Y. S., Khademhosseini, A., and Dokmeci, M. R. (2018). Bioinks for 3D bioprinting: an overview. Biomaterials science, 6(5): 915-946.
Hoffman, W., Volpe, T. A. (2018) Internet of Nuclear Things: Managing the Proliferation Risks of 3D Printing Technology, J. Bull. At. Sci. 74(2): 102-113
Kacarevic, Z. P., Rider, P. M., Alkildani, S., Retnasingh, S., Smeets, R., Jung, O., Ivanisevic, Z. and Barbeck, M. (2018). An introduction to 3D bioprinting: possibilities, challenges and future aspects. Materials, 11(11): 21-99.
Mandrycky, C., Wang, Z., Kim, K., and Kim, D. H. (2016). 3D bioprinting for engineering complex tissues. Biotechnology advances, 34(4): 422-434.
Murphy, S. V., and Atala, A. (2014). 3D bioprinting of tissues and organs. Nature biotechnology, 32(8): 773-785.
Tan, B., Gan, S., Wang, X., Liu, W., and Li, X. (2021). Applications of 3D bioprinting in tissue engineering: advantages, deficiencies, improvements, and future perspectives. Journal of Materials Chemistry B, 9(27):5385-5413.
Vanaei, S., Parizi, M. S., Salemizadehparizi, F., and Vanaei, H. R. (2021). An overview on materials and techniques in 3D bioprinting toward biomedical application. Engineered Regeneration, 2: 1-18.
Vermeulen, N., Haddow, G., Seymour, T. (2017). 3D bioprint me: a socioethical view of bioprinting human organs and tissues, Journal of Medical Ethics 2017 (43): 618-624.
In-Text Citation: (Razak et al., 2022)
To Cite this Article: Razak, S. S. A., Fakhruddin, K., & Razak, S. I. A. (2022). Incorporating Informed Consent in 3d Bioprinting Medical Treatment. International Journal of Academic Research in Business and Social Sciences, 12(8), 751 – 756.
Copyright: © 2022 The Author(s)
Published by Human Resource Management Academic Research Society (www.hrmars.com)
This article is published under the Creative Commons Attribution (CC BY 4.0) license. Anyone may reproduce, distribute, translate and create derivative works of this article (for both commercial and non0-commercial purposes), subject to full attribution to the original publication and authors. The full terms of this license may be seen at: http://creativecommons.org/licences/by/4.0/legalcode